Humacyte, Inc. (HUMA)
1.34
-0.05
(-3.60%)
USD |
NASDAQ |
Jun 10, 16:00
1.04
-0.30
(-22.39%)
Pre-Market: 08:25
Humacyte Price : 1.34 for June 10, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jun 10, 2026 | 1.38 | 1.485 | 1.31 | 1.34 | 7.975M |
| Jun 09, 2026 | 1.38 | 1.50 | 1.32 | 1.39 | 4.747M |
| Jun 08, 2026 | 1.40 | 1.42 | 1.35 | 1.38 | 3.781M |
| Jun 05, 2026 | 1.49 | 1.50 | 1.33 | 1.35 | 6.433M |
| Jun 04, 2026 | 1.39 | 1.525 | 1.38 | 1.49 | 6.604M |
| Jun 03, 2026 | 1.42 | 1.46 | 1.35 | 1.40 | 5.496M |
| Jun 02, 2026 | 1.40 | 1.478 | 1.36 | 1.39 | 8.980M |
| Jun 01, 2026 | 1.30 | 1.48 | 1.286 | 1.45 | 11.10M |
| May 29, 2026 | 1.28 | 1.34 | 1.24 | 1.30 | 9.421M |
| May 28, 2026 | 1.15 | 1.30 | 1.11 | 1.28 | 11.29M |
| May 27, 2026 | 1.11 | 1.21 | 1.10 | 1.15 | 5.846M |
| May 26, 2026 | 1.025 | 1.12 | 1.02 | 1.11 | 7.121M |
| May 22, 2026 | 1.01 | 1.06 | 0.9901 | 1.05 | 3.766M |
| May 21, 2026 | 0.9222 | 1.04 | 0.89 | 1.02 | 6.807M |
| May 20, 2026 | 0.8412 | 0.9299 | 0.8253 | 0.9172 | 4.352M |
| May 19, 2026 | 0.90 | 0.90 | 0.82 | 0.8253 | 4.185M |
| May 18, 2026 | 0.95 | 0.98 | 0.86 | 0.8984 | 6.548M |
| May 15, 2026 | 1.05 | 1.05 | 0.89 | 0.9301 | 7.490M |
| May 14, 2026 | 1.15 | 1.22 | 1.00 | 1.00 | 10.11M |
| May 13, 2026 | 0.8948 | 1.18 | 0.86 | 1.13 | 26.08M |
| May 12, 2026 | 0.97 | 0.9847 | 0.91 | 0.91 | 4.690M |
| May 11, 2026 | 1.04 | 1.05 | 1.00 | 1.00 | 8.063M |
| May 08, 2026 | 1.07 | 1.09 | 1.01 | 1.06 | 5.588M |
| May 07, 2026 | 1.02 | 1.09 | 0.9461 | 1.08 | 9.369M |
| May 06, 2026 | 0.9052 | 0.9924 | 0.88 | 0.9833 | 6.063M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Altimmune, Inc. | 2.61 |
| Protalix Biotherapeutics, Inc. | 1.97 |
| Agenus, Inc. | 3.07 |
| Amgen, Inc. | 337.73 |
| BioCryst Pharmaceuticals, Inc. | 8.19 |
Price Related Metrics
| PS Ratio | 116.05 |
| Price to Book Value | 25.59 |
| Earnings Yield | -42.89% |
| Market Cap | 297.51M |